Vanita Noronha, MBBS MD DM
@VanitaNoronha
Med oncologist @TataMemorial. Ed-in-Chief @CRSTonline, https://t.co/Fr4aHwnOLX. Clinician, researcher, mother, reader. Tweets my own; RTs not endorsements
ID:1414240146
http://crstonline.com 09-05-2013 01:29:47
3,7K Tweets
4,1K Followers
1,4K Following
Follow People
Dr (Prof). Vijay Patil
Professor, Head and Neck, Neuro Thoracic, Medical Oncologist, Chemotherapy, Targetted therapy, Metronomic, Researcher,Immunotherapy, and Phase 1/2/3 studies
Nirmal Raut
Masters of molecular oncology (CNIO ) Medical Oncologist by profession (Lung is close to my heart), researcher by passion, precision oncology,liquid biopsy.
𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM
Consultant Hemato-Oncologist 🇮🇳 | Stem Cell Transplant @pmcancercentre @UHN 🇨🇦 | @UofT | DM Hematology @SGPGI, MD Medicine, LTMMC | Photographer, Drummer
Vivek Subbiah, MD
Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Vincent Rajkumar
Editor-in-Chief, Blood Cancer Journal; Oncologist; Cancer Research; Opinions are solely my personal views https://t.co/HOGYJSpsoG
Long term results of our regimen in EGFR mutation positive NSCLC. The combination is active Vanita Noronha, MBBS MD DM Nandini Menon Dr Amol Akhade Lung Connect India Sewanti Limaye 🇮🇳🇺🇸 Navneet Singh Prabhat Malik jamanetwork.com/journals/jamao…
Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer-Long-Term Results of a Randomized Clinical Trial
Vanita Noronha, MBBS MD DM JAMA Oncology Vivek Subbiah, MD #EGFR #clinicaltrials
#Cancer #Oncology #lungcancer #Gefitinib
jamanetwork.com/journals/jamao…
Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in Lung Cancer Vanita Noronha, MBBS MD DM JAMA Oncology jamanetwork.com/journals/jamao…
Congratulations to GM Gukesh D. for etching his name in chess history as the youngest-ever Challenger! 🌟 India rejoices, and the future of chess shines brighter than ever! 🇮🇳 #FIDECandidates
Gukesh is the Champion of Candidates 🔥❤️🇮🇳
Edit: Abhyudaya Ram
#chess #chess baseindia #gukesh #candidates2024
Just Out
U.S. FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer #NSCLC 🫁 Based on Results from ALINA
fda.gov/drugs/resource…
Christian Rolfo gilberto lopes Narjust Florez, MD, FASCO Stephen V Liu, MD H. Jack West, MD
Thnx for D17 mate .. was missing that Upfront chemo in this any many such scenarios Tata Memorial Hospital ACTREC-TMC .. when the blood testis barrier is possibly no longer there Amit Joshi Vanita Noronha, MBBS MD DM Vedang Murthy Santosh Menon mahendra pal
An analysis of psychological problems in older Indian patients with cancer geriatriconcology.net/article/S1879-… Anita J. Kumar, MD MSCE PhD Vanita Noronha, MBBS MD DM William Dale, MD, PhD, FASCO Supriya Mohile Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #PsychologicalIssues #AdjustmentDisorder
Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly
#CRST #cancer #oncologia #MedTwitter #CancerResearch
Our article published in JGO authors.elsevier.com/c/1iqEA6hK~08W…
Immense gratitude
Vanita Noronha, MBBS MD DM
@kumarprabhash
Anant Ramaswamy
Cancer story has 2 protagonists - pt n caregiver . How does it feel to be a caregiver when ur wife has stage 4 #NSCLC
Thanks Dr Vanita Noronha, MBBS MD DM n Dr Kumar Prabash for ur support that has helped these REAL stories reach out to the world!
Cancer Research, Statistics and Treatment +
journals.lww.com/crst/fulltext/…
Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution.
Read here: bit.ly/3Kf29px
Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #oncology #CancerResearch #MedTwitter
Contralateral nodal relapse in well-lateralised oral cavity cancer: Monali Swain, Ashwini Budrukkar & our Head Neck Oncology team dissect findings from 208 pts treated 2012-2017.
Incidence remains low, common in levels IB & II, ≥2 ipsilateral +ve LN associated with higher risk
Neoadjuvant chemotherapy in locally advanced Sinonasal Teratocarcinosa... sciencedirect.com/science/articl…. One of the first results of its kind Vanita Noronha, MBBS MD DM Ezra Cohen Santam Chakraborty Prathamesh Pai Rakesh Reddy Boya